Market Signal Briefing

Dubai, UAE – December 1, 2025 — Mining pool Neopool reported a record 169 BTC (approximately $15 million USD) in payouts to its global miner network for November 2025. 

This volume reflects Neopool’s expanding market presence and operational performance since its inception earlier this year. Independent data from miningpoolstats.stream continues to rank Neopool as the most efficient mining pool worldwide. 

“Reaching $15 million in monthly payouts is a direct result of the trust our mining partners place in us,” stated Andrei Kapeikin, CEO of Neopool. “We built Neopool to offer more than just scale; we deliver the efficiency, transparent FPPS payouts, and dependable daily settlements that directly enhance miner profitability.” 

The pool’s growth has been rapid, breaking into the global top-15 within months. This performance is driven by proprietary optimization technology, a low-latency global routing infrastructure, and a foundational commitment to transparency. 

The November record was set during a period of increased Bitcoin network difficulty, demonstrating how Neopool’s technical focus provides a competitive edge. 

“Other pools often prioritize hash rate volume,” Kapeikin noted. “We’ve shown that technical excellence and transparency are what ultimately drive value. Our miners’ daily results — and this monthly record — are the proof.” 

Neopool remains focused on advancing its infrastructure and optimization algorithms, strengthening its position as an independent, high-performance alternative for the global mining community. 

For details on performance metrics and mining solutions, visit neopool.com. 

About Neopool 

Neopool is a next-generation Bitcoin mining pool, rapidly achieving a top-15 global ranking and the #1 spot for daily PPS efficiency. Founded by a team with over a century of combined experience in mining and IT, we combine proprietary algorithms, robust infrastructure, and transparent FPPS payouts. We serve miners worldwide with automated daily settlements, a low 0.001 BTC payout threshold, and 24/7 support. 

Contacts: Kseniya PR manager [email protected]

Disclaimer: This is a sponsored press release. Readers are encouraged to perform their own due diligence before acting on any information presented in this article.

Bitcoin Magazine

Established in 2012, Bitcoin Magazine is the oldest and most established source of trustworthy news, information and thought leadership on Bitcoin.

TL;DR

STON.fi launches the first full DAO in the TON ecosystem, allowing users to directly govern protocol decisions through staked STON and ARKENSTON tokens.
The network has over 5.6 million wallets and more than $6.6 billion in total swap volume, reflecting strong usage.
TON trades at $1.61, up 2.22% in the last 24 hours, with a market cap of $3.93 billion, signaling growing interest in AI‑driven DeFi applications.

TON has experienced renewed market attention following STON.fi’s DAO launch, the first complete decentralized governance structure on the network. 

TON Token Gains Momentum Amid New DAO Implementation
The native token currently trades at $1.61, rising 2.22% in the past 24 hours, bringing the market cap to $3.93 billion. The DAO enables staked STON holders to influence decisions through ARKENSTON tokens, which represent proportional voting power based on the amount staked and duration of commitment, supporting long-term protocol sustainability. This framework also opens opportunities for developers to propose technical upgrades, while researchers and analysts monitor performance trends, ensuring that the network evolves with both innovation and stability in mind.

STON.fi DAO Expands Community Governance And Engagement
STON.fi’s DAO allows more than 5.6 million users to propose, discuss, and vote on protocol upgrades. During a four-week testing phase, the community submitted over 115 proposals covering interface improvements, feature additions, and strategic developments. This system ensures that governance is distributed among active users and liquidity providers, establishing a transparent and accountable framework for the TON ecosystem. By integrating real-time analytics and AI-powered voting insights, the DAO strengthens the decision-making process and encourages collaboration across multiple stakeholder groups.

Rising AI-Driven DeFi Activity Supports TON Growth
The protocol benefits from increasing AI-driven trading tools and analytics integration, enhancing efficiency and attracting professional users. STON.fi has processed over 29.8 million operations and more than $6.6 billion in swap volume, securing its position as the primary DeFi hub on TON. Analysts note that the combination of DAO governance and AI adoption could further improve liquidity, boost token utility, and strengthen the network’s overall adoption. Additionally, growing AI-enhanced strategies are helping smaller investors navigate market volatility, contributing to a more resilient ecosystem that combines innovation, accessibility, and community oversight.

The STON.fi DAO rollout demonstrates practical decentralization and active community participation. Coupled with AI-enhanced demand and ongoing DeFi expansion, TON’s ecosystem is positioned for continued growth, with users now playing a direct role in shaping both the protocol’s development and the network’s future financial landscape.

Ethereum has reclaimed the $3,000 level after a strong market reaction to improving macro conditions, offering investors a much-needed shift in momentum. The move comes just days after the Federal Reserve officially ended Quantitative Tightening (QT), a policy shift that immediately boosted liquidity expectations across all risk assets. With markets now pricing in an imminent interest rate cut, confidence has begun to return, and ETH is one of the first major assets to respond.

This rebound reflects more than just macro relief. According to data from Arkham, shared by Lookonchain, Bitmine continues to accumulate Ethereum at current prices, reinforcing bullish sentiment at a moment when many traders remain cautious. Bitmine’s persistent buying throughout the correction has become one of the most influential signals for on-chain analysts, suggesting that large players see long-term value even as the market wrestles with volatility.

Reclaiming $3,000 places Ethereum back above a key psychological level, and the combination of supportive macro policy and whale accumulation provides a stronger foundation than the market had just weeks ago.

Bitmine and Linked Wallets Expand Ethereum Holdings
According to data from Arkham reported by Lookonchain, Bitmine has purchased another 18,345 ETH, worth approximately $54.94 million, just a few hours ago. This marks yet another large buy in a growing series of aggressive accumulation moves that Bitmine has made throughout the correction. Their continued willingness to buy at current levels signals strong confidence in Ethereum’s long-term value, even as the market navigates heightened volatility.

Bitmine-Linked Wallet Transfers | Source: Arkham
Shortly after this report, Lookonchain highlighted activity from a newly created wallet, 0x52B7, which withdrew 30,278 ETH—valued at $91.16 million—from Kraken. The size and timing of the withdrawal have led analysts to speculate that this wallet may be linked to Bitmine or part of a broader accumulation strategy.

Large withdrawals from exchanges typically indicate that the owner intends to hold the assets off-exchange, often for long-term storage or staking, rather than preparing to sell.

Bitmine-Linked Wallet Transfers | Source: Arkham
If the wallet is indeed connected to Bitmine, this would bring their latest combined accumulation to nearly 50,000 ETH in a single day. Such behavior suggests strategic positioning ahead of potential macro-driven upside or internal confidence in Ethereum’s recovery.

This kind of synchronized whale activity often precedes significant price shifts, reinforcing the idea that large players are preparing for a stronger market phase.

ETH Reclaims $3,000 But Still Faces Key Resistance
Ethereum’s 3-day chart shows a notable improvement after reclaiming the $3,000 level, but the broader trend still carries signs of fragility. The recent bounce followed a deep corrective move that sent ETH from the $4,500 region down to the $2,700–$2,800 support zone, where buyers finally stepped in with conviction. The strong lower wicks around this area confirm that demand remains active, but Ethereum has yet to fully recover its bullish structure.

ETH consolidates around key level | Source: ETHUSDT chart on TradingView
Price now trades just below the 50 SMA, which sits near the $3,100–$3,150 zone—an important short-term resistance level. A clean break above this moving average would signal renewed momentum and increase the chances of retesting the $3,400–$3,600 range. Meanwhile, the 100 SMA and 200 SMA remain slightly above price, reflecting the broader downtrend that has dominated since September.

Volume has picked up slightly during the recovery, but it remains muted compared to the selling spikes seen during the drawdown. This indicates cautious buying rather than aggressive accumulation at these levels. To confirm a trend reversal, ETH must close above the 50 SMA and then challenge the cluster of resistance around $3,200–$3,300.

Featured image from ChatGPT, chart from TradingView.com

What fear is lurking beneath the surface of Trump-linked crypto stocks?

Solana (CRYPTO: SOL) gained attention on Wednesday after SkyBridge founder Anthony Scaramucci said the blockchain is positioned to become an industry standard for tokenized assets.

Scaramucci Predicts Three Or Four Winners In BlockchainScaramucci told CNBC that tokenization will drive the next stage of digital finance as smart contracts move onto fast and inexpensive blockchain rails. 

He said Solana offers unique technical properties that position it as a leading platform for developers.

Skybridge founder compared today's competition to early cloud providers, noting that several major winners could emerge over the next five years. 

He said Solana, Bitcoin (CRYPTO: BTC) and Avalanche (CRYPTO: AVAX) are among the networks with strong advantages as the market matures.

Scaramucci said Solana succeeds because its architecture uses existing computing concepts rather than untested designs. 

He argued this makes it easier for developers to build applications, which strengthens long-term adoption.

SkyBridge Holds Significant Solana ExposureScaramucci said Solana is a core position for SkyBridge and for his personal holdings. 

He said the firm invested early, similar to its Bitcoin strategy five years ago. 

He added that many critics later reversed their views once institutional adoption expanded.

Scaramucci said he expects Solana to follow a similar path and believes today's price levels may look attractive in hindsight. 

He framed Solana as one of the few networks likely to become a global standard for tokenization and high-throughput applications.

Solana Bulls Try To Break A Key Downtrend

SOL Price Prediction as of December 3rd (Source: TradingView)

Solana trades near $141 after rebounding from the $120 to $125 support zone, which has held through several waves of selling. 

The latest bounce shows firm demand at that level and marks a gain of about 16% from recent lows.

The recovery faces strong resistance as multiple moving averages sit above price. 

A descending trendline from September continues to cap every rally and remains the main barrier for bulls. 

The first major test sits between $155 and $158, where the supertrend indicator and the 20-day EMA converge.

A confirmed break above that zone may open the path toward the $171 to $176 region, which aligns with the 100-day and 200-day EMAs. 

Failure at resistance may draw price back toward $130, with renewed fear risking another retest of $120. 

Traders note that the trend remains bearish until SOL closes above $158 and holds above $176.

Read Next:

Snowflake Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Image: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Bitcoin

Ad Disclosure

Ad Disclosure

We believe in full transparency with our readers. Some of our content includes affiliate links, and we may earn a commission through these partnerships. However, this potential compensation never influences our analysis, opinions, or reviews. Our editorial content is created independently of our marketing partnerships, and our ratings are based solely on our established evaluation criteria. Read More

Ad Disclosure

Ad Disclosure

We believe in full transparency with our readers. Some of our content includes affiliate links, and we may earn a commission through these partnerships. However, this potential compensation never influences our analysis, opinions, or reviews. Our editorial content is created independently of our marketing partnerships, and our ratings are based solely on our established evaluation criteria. Read More

Crypto Journalist

Anas Hassan

Crypto Journalist

Anas Hassan

About Author

Anas is a crypto native journalist and SEO writer with over five years of writing experience covering blockchain, crypto, DeFi, and emerging tech.

Has Also Written

Ad Disclosure

Ad Disclosure

We believe in full transparency with our readers. Some of our content includes affiliate links, and we may earn a commission through these partnerships. However, this potential compensation never influences our analysis, opinions, or reviews. Our editorial content is created independently of our marketing partnerships, and our ratings are based solely on our established evaluation criteria. Read More

Last updated: 

December 3, 2025

Strategy (formerly MicroStrategy) is facing growing pressure to sell part of its Bitcoin holdings, potentially breaking Chairman Michael Saylor’s “never sell your Bitcoin” mantra, in a development analysts say could become a pivotal signal for Bitcoin price prediction heading into 2026.

Bitcoin’s sharp decline from October’s high near $126,000 to below $84,000 has compressed the value of Strategy’s holdings and pressured its MSTR stock, creating an unprecedented scenario that could force Strategy’s first meaningful Bitcoin sale since 2020.

Two Critical Triggers for Strategy’s Bitcoin SaleStrategy CEO Phong Le outlined that selling Bitcoin would only occur under extremely specific conditions that must align simultaneously.

The first trigger is if the company’s mNAV falls below 1.0, meaning its market capitalization drops to or below the value of the Bitcoin it holds.

The second condition is that capital access dries up entirely if investors refuse to purchase Strategy’s equity or preferred stock at viable terms.

The prospect of Strategy offloading even a fraction of its Bitcoin holdings has created significant anxiety across the crypto market.

Gnomo Labs Founder Gabo believes the first reaction zone for Bitcoin sits around $86,000-$88,000, but the critical support level lies at $79,000-$82,000, where long-term holders and institutions typically step in.

Pierre Rochard, CEO of The Bitcoin Bond Company, offered a contrasting view.

He told Cryptonews that Strategy would only face true financial jeopardy under a combination of government budget surpluses, declining national debt, and high real interest rates.

He added: “Without those factors in place, there is structural support for Strategy as fiat money printing drives Bitcoin adoption.”

Rochard also downplayed the potential impact, noting: “The Bitcoin market has sustained more mass panics over the past 16 years than any other asset, as it climbed in value from $0 to more than $1 trillion.”

Bitcoin Price Prediction: BTC Targets $100k BreakoutBitcoin is currently testing the $93,000 resistance zone, a structurally necessary level that coincides with a descending trendline and a supply block.

MACD has flipped bullish with a strong cross above the signal line, suggesting buyers maintain control.

Source: TradingViewA decisive close above $93,000 would open the path toward $98,700, with larger Fibonacci targets at $103,000, $107,000, and eventually $110,000 if momentum accelerates.

However, rejection at this level could trigger a brief retrace toward $90,000 before another breakout attempt.

Investors Turn to Maxi Doge Amid UncertaintyWhile the market remains undecided on Bitcoin’s direction due to uncertainties surrounding Strategy’s position and broader macro factors, investors are increasingly exploring alternative opportunities like Maxi Doge ($MAXI)

The Ethereum-based meme coin features a gym-enthusiast Doge mascot and positions itself as a high-energy lifestyle token with staking rewards and trading competitions.

The presale has raised over $4.25 million, with the current token price around $0.000271 and hours remaining before the next price increase.

Holders gain passive income through staking yields, with higher yields being offered on a first-come first first-served basis.

To join the presale, visit the official Maxi Doge Website and connect any compatible wallet, such as Best Wallet.

You can swap existing crypto or use a bank card to complete the transaction in seconds.

Visit the Official Maxi Doge Website Here

Follow us on Google News

PARSIPPANY, NJ, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCID: IDXG) (“Interpace” or the “Company”) today announced that it has fully repaid its outstanding term loan facility with BroadOak Capital Partners (“BroadOak”) prior to the facility’s maturity date.

The repayment satisfies the Company’s obligations under the Loan and Security Agreement originally entered into on October 29, 2021, with BroadOak Fund V, L.P. By retiring this debt early, Interpace eliminates related interest expenses, providing increased operational flexibility to support future growth.

“The early repayment of the BroadOak facility is a significant milestone for Interpace and a testament to our robust financial performance and disciplined capital management,” said Chris McCarthy, Chief Financial Officer. “Over the past several years, BroadOak has been a valuable partner, supporting our strategic turnaround and transition to profitability. With this debt retired, we have strengthened our balance sheet, positioning us to focus our full resources on driving commercial growth as we continue to deliver record testing volumes and revenue for our thyroid tests.”

About Interpace Biosciences

Interpace Biosciences is an emerging leader in enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications.

Clinical services, through Interpace Diagnostics, provide clinically useful molecular diagnostic tests and bioinformatics and pathology services for evaluating risk of cancer by leveraging the latest technology in personalized medicine for improved patient diagnosis and management. Interpace has two commercialized molecular tests: ThyGeNEXT for the diagnosis of thyroid cancer from thyroid nodules utilizing a next-generation sequencing assay and ThyraMIRv2, used in combination with ThyGeNEXT, for the diagnosis of thyroid cancer utilizing a proprietary microRNA pairwise expression profiler along with algorithmic classification.

For more information, please visit Interpace Biosciences’ website at www.interpace.com.

Forward-looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, relating to the Company’s future financial and operating performance. The Company has attempted to identify forward-looking statements by terminology including “believes,” “estimates,” “anticipates,” “expects,” “plans,” “projects,” “intends,” “potential,” “may,” “could,” “might,” “will,” “should,” “approximately” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are based on current expectations, assumptions and uncertainties involving judgments about, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond the Company’s control. These statements also involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to be materially different from those expressed or implied by any forward-looking statements, including, but not limited to, the possibility that the Company’s estimates of future revenue and cash flows may prove to be materially inaccurate, the Company’s prior history of operating losses, the Company’s ability to adequately finance its business and seek alternative sources of financing, the Company’s dependence on sales and reimbursements from its clinical services, the Company’s ability to retain or secure reimbursement including its reliance on third parties to process and transmit claims to payers and the adverse impact of any delay, data loss, or other disruption in processing or transmitting such claims, the Company’s revenue recognition being based in part on estimates for future collections which estimates may prove to be incorrect, and the Company’s ability to continue to restructure itself in light of the loss of reimbursement for its PancraGEN product.

Additionally, all forward-looking statements are subject to the “Risk Factors” detailed from time to time in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, as amended, Current Reports on Form 8-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission. Because of these and other risks, uncertainties and assumptions, undue reliance should not be placed on these forward-looking statements. In addition, these statements speak only as of the date of this press release and, except as may be required by law, the Company undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

Contacts:

Investor Relations
Interpace Biosciences, Inc.
(855)-776-6419
[email protected]

Mattel, Inc. (MAT) Morgan Stanley Global Consumer & Retail Conference 2025 December 3, 2025 9:30 AM EST

Company Participants

Ynon Kreiz - Executive Chairman & CEO
Paul Ruh - Chief Financial Officer

Conference Call Participants

Megan Christine Alexander - Morgan Stanley, Research Division

Presentation

Megan Christine Alexander
Morgan Stanley, Research Division

Okay. Good morning, everyone. A quick disclaimer before we start. Important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. For any questions, you can reach out to your Morgan Stanley sales rep.

So again, good morning, everyone. Welcome, day 2 of the Morgan Stanley 2025 Global Consumer and Retail Conference. I'm Megan Clapp. I am the U.S. food and leisure analyst here at Morgan Stanley. And really glad to be here today with Mattel, the company's CEO, Ynon Kreiz; and CFO, Paul Ruh.

Mattel probably needs no introduction, but global toy and family entertainment company, leading brands like Barbie, Hot Wheels, Fisher-Price. Company operates an IP-driven model spanning toys, consumer products, digital gaming and a growing film and TV partnership business through their company, Mattel Films.

So again, thank you both so much for being here during what's a busy time.

Ynon Kreiz
Executive Chairman & CEO

Thank you for inviting us.

Question-and-Answer Session

Megan Christine Alexander
Morgan Stanley, Research Division

So Ynon, last year, sitting on the stage at this time, you described Mattel as an IP company managing franchises rather than just a toy maker, which is maybe how people have thought about the business historically. As you think over the past year, can you just talk about how your perspective on the company's position has evolved beyond some of the organizational changes we've seen you implement this year? What other tangible shifts have you seen in how you manage the business and allocate resources?

Recommended For You

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds CarMax, Inc. (“CarMax” or the “Company”) (NYSE: KMX) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

Should You Join This Class Action Lawsuit?

Do you, or did you, own shares of CarMax, Inc. (NYSE: KMX)?
Did you purchase your shares between June 20, 2025 and November 5, 2025, inclusive?
Did you lose money in your investment in CarMax, Inc.?
If you purchased or acquired CarMax securities, and/or would like to discuss your legal rights and options please visit CarMax, Inc. Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or [email protected].

A lawsuit was filed in the United States District Court for the District of Maryland on behalf of investors (the “Class”) who purchased or acquired the securities of CarMax between June 20, 2025 and November 5, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers.

According to the lawsuit, Defendants made misrepresentations concerning CarMax’s growth prospects.

If you wish to serve as lead plaintiff for the Class, you must file papers by January 2, 2026. A lead plaintiff is a representative party acting on other class members behalf in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for sixteen consecutive years.

ATTORNEY ADVERTISING. © 2025 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Peter Allocco
Investor Relations Manager
Bernstein Liebhard LLP
https://www.bernlieb.com
(212) 951-2030
[email protected]

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

Should You Join This Class Action Lawsuit?

Do you, or did you, own shares of MoonLake Immunotherapeutics (NASDAQ: MLTX)?Did you purchase your shares between March 10, 2024 and September 29, 2025, inclusive?Did you lose money in your investment in MoonLake Immunotherapeutics? If you purchased or acquired MoonLake common stock, and/or would like to discuss your legal rights and options please visit MoonLake Immunotherapeutics Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or [email protected].

A lawsuit was filed in the United States District Court for the Southern District of New York on behalf of investors (the “Class”) who purchased or acquired the common stock of MoonLake between March 10, 2024 and September 29, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers.

According to the lawsuit, Defendants made misrepresentations concerning the Company’s sole drug candidate, sonelokimab (SLK), which was promoted as superior to competing monoclonal antibody drugs.

If you wish to serve as lead plaintiff for the Class, you must file papers by December 15, 2025. A lead plaintiff is a representative party acting on other class members’ behalf in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for sixteen consecutive years.

ATTORNEY ADVERTISING. © 2025 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Peter Allocco
Investor Relations Manager
Bernstein Liebhard LLP
https://www.bernlieb.com
(212) 951-2030
[email protected]

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

Should You Join This Class Action Lawsuit?

Do you, or did you, own shares of DexCom, Inc. (NASDAQ: DXCM)?Did you purchase your shares between January 8, 2024 and September 17, 2025, inclusive?Did you lose money in your investment in DexCom, Inc.? If you purchased or acquired DexCom securities, and/or would like to discuss your legal rights and options please visit DexCom, Inc. Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or [email protected].

A lawsuit was filed in the United States District Court for the Southern District of New York on behalf of investors (the “Class”) who purchased or acquired the securities of DexCom between January 8, 2024 and September 17, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers.

According to the lawsuit, Defendants made misrepresentations concerning the accuracy, reliability, and functionality of the Dexcom G7 continuous glucose monitoring system, as well as purported enhancements to the device and the ramping up of the Company’s manufacturing facilities.

If you wish to serve as lead plaintiff for the Class, you must file papers by December 26, 2025. A lead plaintiff is a representative party acting on other class members’ behalf in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for sixteen consecutive years.

ATTORNEY ADVERTISING. © 2025 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Peter Allocco
Investor Relations Manager
Bernstein Liebhard LLP
https://www.bernlieb.com
(212) 951-2030
[email protected]

LOS ANGELES, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises DeFi Technologies, Inc., (“DeFi” or the "Company") (NASDAQ: DEFT) investors off a class action on behalf of investors that bought securities between May 12, 2025 and November 14, 2025, inclusive (the “Class Period”). DeFi investors have until January 30, 2026 to file a lead plaintiff motion.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or join the case via https://portnoylaw.com/defi-technologies-inc. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) DeFi Technologies was facing delays in executing its DeFi arbitrage strategy, which at all relevant times was a key revenue driver for DeFi Technologies; (2) DeFi Technologies had understated the extent of competition it faced from other digital asset treasury (“DAT”) companies and the extent to which that competition would negatively impact its ability to execute its DeFi arbitrage strategy; (3) as a result of the foregoing issues, DeFi Technologies was unlikely to meet its previously issued revenue guidance for the fiscal year 2025; (4) accordingly, defendants had downplayed the true scope and severity of the negative impact that the foregoing issues were having on DeFi Technologies’ business and financial results; and (5) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bar
[email protected]
310-692-8883
www.portnoylaw.com

Attorney Advertising

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds James Hardie Industries plc (“James Hardie” or the “Company”) (NYSE: JHX) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

Should You Join This Class Action Lawsuit?

Do you, or did you, own shares of James Hardie Industries plc (NYSE: JHX)?Did you purchase your shares between May 20, 2025 and August 18, 2025, inclusive?Did you lose money in your investment in James Hardie Industries plc? If you purchased or acquired James Hardie common stock, and/or would like to discuss your legal rights and options please visit James Hardie Industries plc Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or [email protected].

A lawsuit was filed in the United States District Court for the Northern District of Illinois on behalf of investors (the “Class”) who purchased or acquired the common stock of James Hardie between May 20, 2025 and August 18, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers.

According to the lawsuit, Defendants misrepresented that the Company’s North America Fiber Cement segment remained strong despite the challenging market environment.

If you wish to serve as lead plaintiff for the Class, you must file papers by December 23, 2025. A lead plaintiff is a representative party acting on other class members’ behalf in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for sixteen consecutive years.

ATTORNEY ADVERTISING. © 2025 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Peter Allocco
Investor Relations Manager
Bernstein Liebhard LLP
https://www.bernlieb.com
(212) 951-2030
[email protected]

We gebruiken cookies en gegevens voor het volgende:

Google-services leveren en onderhoudenUitval bijhouden en bescherming bieden tegen spam, fraude en misbruikDoelgroepbetrokkenheid en sitestatistieken meten om inzicht te krijgen in hoe onze services worden gebruikt en de kwaliteit van die services te verbeterenAls je Alles accepteren kiest, gebruiken we cookies en gegevens ook voor het volgende:

Nieuwe services ontwikkelen en verbeterenAdvertenties laten zien en de effectiviteit ervan metenGepersonaliseerde content laten zien (afhankelijk van je instellingen)Gepersonaliseerde advertenties laten zien (afhankelijk van je instellingen)Als je Alles afwijzen kiest, gebruiken we cookies niet voor deze aanvullende doeleinden.

Niet-gepersonaliseerde content en advertenties worden beïnvloed door factoren zoals de content die je op dat moment bekijkt en je locatie (voor advertenties wordt je algemene locatie gebruikt). Gepersonaliseerde content en advertenties kunnen bijvoorbeeld ook videoaanbevelingen, een aangepaste YouTube-homepage en op jou toegespitste advertenties omvatten die zijn gebaseerd op eerdere activiteit, zoals de video's die je bekijkt en de items waarnaar je zoekt op YouTube. We gebruiken cookies en gegevens ook om te zorgen dat de functionaliteit geschikt is voor je leeftijd, als dit relevant is.

Selecteer Meer opties om meer informatie te bekijken, waaronder informatie over hoe je je privacyinstellingen beheert. Je kunt ook altijd naar g.co/privacytools gaan.

CHICAGO, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced a long-term strategic partnership with Prime Ledger LLC ("Prime Ledger"), a leading provider of blockchain infrastructure services and digital asset treasury management. This multi-phase agreement is centered on a comprehensive digital transformation of Cosmos Health’s financial operations, including participating in the management of its $300,000,000 treasury facility and the tokenization of high-value intellectual property (IP).

This collaboration will be executed in several phases, beginning with the establishment of a compliant and secure framework for Digital Asset Treasury (DAT) management. Prime Ledger will help oversee Cosmos Health’s $300M treasury, implementing sophisticated controls, protocol, and reporting systems to enhance efficiency and security while managing risk, yield and income in its corporate treasury operations.

A cornerstone of the partnership involves the tokenization of various IP assets owned by Cosmos Health. Prime Ledger will design and deploy a token issuance platform, enabling Cosmos Health to unlock new capitalization channels and model investments based on its extensive portfolio of healthcare and wellness innovations.

Furthermore, the agreement includes the integration of Cosmos Health’s data infrastructure using Prime Ledger's existing relationship with Conduit Network. This will allow Cosmos Health to more effectively manage its complex on-chain and off-chain data (i.e. data that is permanently recorded, stored, and verifiable on a public blockchain's distributed ledger and data that is external to a blockchain), consolidating flows for financial reporting, regulatory compliance, and real-time performance analytics.

Greg Siokas, CEO of Cosmos Health, stated: “This partnership with Prime Ledger is a pivotal step in our evolution, positioning Cosmos Health at the forefront of the digital economy in the healthcare sector. By digitizing our treasury and tokenizing our valuable IP, we are not just enhancing efficiency; we are building new pathways for growth and innovation. Prime Ledger’s expertise provides the secure and scalable infrastructure we need to achieve these strategic goals.”

Robert Hoffman, CEO of Prime Ledger, commented: “We are honoured that Cosmos Health has selected Prime Ledger for this transformative initiative. Managing a significant treasury and tokenizing unique IP requires a blend of deep financial security, data integrity, and blockchain expertise. Our platforms are built for this exact purpose. We are fully committed to supporting Cosmos's long-term vision and setting a new standard for digital finance in the global healthcare industry."

The initial phase of the engagement is set to commence in Q4 2025 and will focus on strategy, regulatory mapping, and the architectural design of the treasury and tokenization platforms.

About Prime Ledger LLC
Prime Ledger LLC is a premier provider of digital asset and blockchain infrastructure services. The firm specializes in secure digital asset treasury management, full-lifecycle asset tokenization, and big data integration for enterprise clients, enabling corporations to navigate the digital finance ecosystem.

About Cosmos Health Inc.
Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at www.cosmoshealthinc.com, www.skypremiumlife.com, www.cana.gr, www.zipdoctor.co, www.cloudscreen.gr, as well as LinkedIn and X.

Forward-Looking Statements
With the exception of the historical information contained in this news release, the matters described herein may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “believes,” “expects,” “anticipates,” “intends,” “projects,” “estimates,” “plans,” and similar expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could,” generally identify forward-looking statements, although not all forward-looking statements contain these words. These statements involve risks and uncertainties that may individually or materially affect the matters discussed herein for a variety of reasons outside the Company’s control, including, but not limited to: the Company’s ability to raise sufficient financing to implement its business plan; the effectiveness of its digital asset strategies, including accumulation and yield-generating activities; the impact of the war in Ukraine on the Company’s business, operations, and the economy in general; and the Company’s ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward-looking statements, as actual results could differ materially from those anticipated. Readers are encouraged to review the risk factors set forth in the Company’s filings with the SEC, which are available at the SEC’s website (www.sec.gov). The Company disclaims any obligation to update or revise forward-looking statements, whether as a result of any new information, future events, or otherwise.

Investor Relations Contact:
BDG Communications
[email protected]

December 03, 2025 12:22 PM EST | Source: Metaguest.AI Incorporated
Toronto, Ontario--(Newsfile Corp. - December 3, 2025) - Metaguest.AI Incorporated (CSE: METG) (OTCQB: MGSTF) ("Metaguest" or the "Company") an AI technology company transforming the hospitality sector through intelligent guest engagement, announced today the final closing of its secured loan facility of up to $1,000,000 (the "Facility"), originally announced on May 9, 2025 and reaffirmed throughout the year.

The Company has completed a final closing under this Facility, adding $34,000 in gross proceeds and bringing total funds raised under the program to $451,000. This closing marks the completion of Metaguest's 2025 secured debt financing initiative, which has supported ongoing operations and product deployment across the Company's AI-driven platform.

Each loan under the Facility bears interest at 12% per annum and includes a 12% loan advance fee, payable in Class A Common Shares of Metaguest at a deemed price of $0.10 per share. The loan advance fee for this closing will be satisfied through the issuance of 40,800 Class A Common Shares. The loans are secured by a general security agreement over the Company's assets, rank pari passu with existing secured obligations, and carry a 12-month term, extendable for an additional six months at Metaguest's option.

"This final closing allows us to conclude our 2025 secured financing program and move forward with clarity into our next operating phase," said Colin Keddy, Director of Metaguest.AI. "We appreciate the continued support of our investors as we advance our platform and customer deployments."

For more information about investing with Metaguest.AI, please contact Colin Keddy, Director at [email protected]

About Metaguest.AI Incorporated

Metaguest.AI is a next-generation technology company focused on enhancing the guest experience through advanced AI solutions. Its flagship platform provides an end-to-end guest engagement ecosystem, covering everything from pre-arrival to post-departure. Features include on-property e-commerce with digital payments, real-time service requests, mobile check-out, personalized in-room controls, local experience and event bookings, and a multilingual virtual concierge—all accessible without downloading an app or visiting a website. Hotels, resorts, and short-term rental operators use Metaguest to boost efficiency, drive incremental revenue, and elevate customer satisfaction.

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276801

MS&AD Insurance Group Holdings, Inc. (OTCPK:MSADY) Discusses Planned Merger, Strategic Investments, and Shareholding Unwinding Initiatives November 27, 2025 2:00 AM EST

Company Participants

Shinichiro Funabiki - President, CEO & Representative Director
Shigeo Kudo - Group CFO, EVP-Corp, Corp comm, IR, Internal Audit Dept, Capital Policy, VP & EO and Director
Hironori Morimoto - Executive Officer

Conference Call Participants

Kazuki Watanabe - Daiwa Securities Co. Ltd., Research Division
Masao Muraki - SMBC Nikko Securities Inc., Research Division
Koki Sato - JPMorgan Chase & Co, Research Division
Atsuro Takemura - Morgan Stanley, Research Division
Ryusei Mashima - Tokai Tokyo Intelligence Laboratory Co., Ltd.
Natsumu Tsujino - BofA Securities, Research Division
Naruhiko Sakamaki - Mizuho Securities Co., Ltd., Research Division
Futoshi Sasaki - Nomura Securities Co. Ltd., Research Division

Presentation

Unknown Executive

Good afternoon, ladies and gentlemen. Thank you very much for participating in the MS&AD Insurance Group Holdings Fiscal Year 2025 Second Information Meeting today. I am Hayashi from the IR department, and I will serve as a host and moderator. Thank you for your attention.

Before we begin, I'd like to provide guidance regarding the audio and materials. The original audio will be in Japanese. [Operator Instructions]

Today's materials are available on our official website. Please select Investor Relations and IR Events from the top screen and view the section Fiscal Year 2025 Second Information Meeting. Also, I would like to apologize and inform you about correction to the materials.

We have added 2 details in the latest version of the materials published on the official website this afternoon. The revised version has been distributed to those participating in the venue and the materials currently on the official website for those participating online are the correct ones. So please check them.

The first correction is on Page 21, where information about the revision planned for January 2026 has been

Recommended For You

Vital Farms, Inc. (VITL) Morgan Stanley Global Consumer & Retail Conference 2025 December 3, 2025 8:00 AM EST

Company Participants

Thilo Wrede - CFO, Chief Accounting Officer & principal accounting officer
Russell Diez-Canseco - President, CEO & Director

Conference Call Participants

Megan Christine Alexander - Morgan Stanley, Research Division

Presentation

Megan Christine Alexander
Morgan Stanley, Research Division

All right. Good morning, everyone. Just a quick disclaimer before we start. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. Any questions, reach out to your Morgan Stanley sales rep.

So welcome, everyone. Day 2 of the Morgan Stanley 2025 Global Consumer and Retail Conference, I'm the Megan Clapp, U.S. food analyst here at Morgan Stanley. Really pleased to be here this morning, kicking off the day with Vital Farms and the company's President and CEO, Russell Diez-Canseco; and CFO, Thilo Wrede. I hope I got that right?

Thilo Wrede
CFO, Chief Accounting Officer & principal accounting officer

Very nice.

Megan Christine Alexander
Morgan Stanley, Research Division

Vital Farms maybe needs some introduction, but very briefly, a leading U.S. supplier of pasture-raised eggs, ethical products. They have a unique strategy partnering with family farms, focused on animal welfare, transparency and premium sustainable food offerings.

Russell, maybe we can start with you. You can do a much better job of explaining the story than me, but...

Russell Diez-Canseco
President, CEO & Director

You got it.

Question-and-Answer Session

Megan Christine Alexander
Morgan Stanley, Research Division

Just maybe for those that are newer to the story, either in the room on the webcast, maybe you can just start with a bit of a high-level overview of the business, the core egg portfolio, your pasture-raised differentiation, the farm network, the Egg Central Station and what you think sets Vital Farms apart in today's staples and food landscape?

Recommended For You

Organon & Co. (OGN) Piper Sandler 37th Annual Healthcare Conference December 3, 2025 10:00 AM EST

Company Participants

Joseph Morrissey - Interim CEO & Executive VP and Head of Manufacturing & Supply
Matthew Walsh - Executive VP & CFO

Conference Call Participants

David Amsellem - Piper Sandler & Co., Research Division

Presentation

David Amsellem
Piper Sandler & Co., Research Division

Good morning, everyone. Welcome to day 2 of the 37th Annual Piper Sandler Healthcare Conference. This is David Amsellem from the Piper Biopharma research team, and we've got Organon with us. We have Joe Morrissey, Interim CEO; and Matt Walsh, CFO. Thanks, gentlemen, for joining us.

Question-and-Answer Session

David Amsellem
Piper Sandler & Co., Research Division

And so certainly lots to talk about. And I wanted to dive right into my questions. And let's just start with the internal investigation and the completion of that. And just as a refresher for people here and listening in on the webcast, just talk about the conclusion of the investigation and then also talk about your remediation efforts.

Joseph Morrissey
Interim CEO & Executive VP and Head of Manufacturing & Supply

Yes, sure. Well, it's great to be here. Yes, the conclusion of investigation was in sales practices in the United States with NEXPLANON and 2 wholesalers. And the ultimate weakness was tone at top, right, which held accountable from a CEO standpoint out of the U.S. We're good that the investigation has been fully completed at this point. We have a very detailed remediation plan that's approved by the Audit Committee on the Board. Matt and I are the cosponsors of that remediation plan.

And being that with tone at the top, it really does start with the tone at the top and how we engage the organization. It goes into the training of

Recommended For You

As of December 3, MicroStrategy Incorporated (MSTR) finds itself at the center of a significant market anomaly. The firm’s market capitalization has plummeted to around $50.7 billion, while its Bitcoin reserves are valued at approximately $60.4 billion. This disconnect suggests that investors can effectively buy the company’s substantial Bitcoin holdings at a discount, while seemingly attributing a negative value to the company’s software and consulting services.

This unusual situation has prompted a sharp debate among analysts and investors. The valuation gap has emerged during a period of significant stock sell-off for MSTR, with shares dropping about 57% since early October. The underlying factors include increased margin requirements set by JPMorgan for MSTR trading, a rise in short interest, and potential reclassification by index provider MSCI. The reclassification could lead to institutional selling on a massive scale, estimated at $2.8 billion, should MSTR be removed from certain stock indices.

The MSCI’s forthcoming decision on whether to retain firms with significant Bitcoin holdings in its indices is crucial. The removal of MSTR could trigger mandatory sales by index funds, as they typically follow the indexed components without discretion. This scenario has fueled speculation that external factors rather than the intrinsic value of MicroStrategy’s operations are driving the decline in stock value.

In response to the turbulence, MicroStrategy has bolstered its financial position by securing a $1.44 billion cash reserve, aimed at covering dividend and interest payments for the next 21 months. This move, funded by prior stock sales, is seen as a strategy to navigate short-term market instability. Executive Chairman Michael Saylor described it as a necessary step, though it sparked mixed reactions. CEO Phong Le’s mention of possibly liquidating Bitcoin holdings to fund dividends was particularly contentious, as it seemed to contradict the company’s previous commitment to holding its Bitcoin assets indefinitely.

Supporters argue that the cash reserve enhances the company’s financial stability by reducing the risk of forced Bitcoin sales. Investor Adam Livingston praised the move as a strategic liquidity pivot that demonstrates financial prudence. However, the decision has also renewed discussions about the risks associated with such a concentrated Bitcoin position. Currently, MicroStrategy controls over 3% of the total Bitcoin supply, a level of concentration that some analysts, like crypto commentator Ran Neuner, warn could pose significant risks, particularly if used for further acquisitions.

The debate around concentration risk is not new. In the broader context, such risks have historically led to volatility in financial markets when significant stakeholders make moves that influence asset prices. For instance, when large entities hold substantial positions in any security, their actions can lead to ripple effects across the market. This is of particular concern in the crypto market, known for its sensitivity to large trades and the actions of major holders or “whales.”

MicroStrategy’s situation is indicative of the unique challenges faced by companies heavily invested in volatile assets like Bitcoin. The firm’s pioneering role in integrating Bitcoin into its corporate strategy has been both celebrated and scrutinized. As Bitcoin’s price itself is subject to significant fluctuations, the financial strategies undertaken by MicroStrategy offer a learning curve for businesses considering similar paths.

Despite the potential advantages of holding substantial Bitcoin reserves, the inherent volatility of the cryptocurrency market poses significant risks. Bitcoin’s price has experienced wild swings in the past, and any downturn could adversely affect companies like MicroStrategy, despite their intentions to hold long-term. Furthermore, regulatory scrutiny around cryptocurrency holdings continues to evolve, potentially impacting how firms account for and manage these assets.

The ongoing adjustments in institutional requirements, like those from JPMorgan and MSCI, highlight another layer of pressure. Financial institutions are increasingly cautious about the risk profiles of companies with substantial crypto holdings, influencing trading conditions and market perceptions. These institutional responses are part of a broader trend where traditional financial systems adapt to the growing presence of cryptocurrencies in corporate treasuries.

In contrast to the potential pitfalls, some argue that MicroStrategy’s approach could serve as a hedge against traditional market risks. Bitcoin’s decentralized nature and limited supply are often cited as advantages in an era of monetary policy uncertainty. As central banks globally deal with inflationary pressures and adjust interest rates, Bitcoin’s appeal as a store of value remains a topic of active debate.

The dynamics surrounding MicroStrategy’s valuation reflect broader themes in the integration of cryptocurrencies into conventional business strategies. As the financial landscape continues to evolve with the inclusion of digital assets, companies and investors alike must navigate the complex interplay of market forces, regulatory environments, and inherent asset risks. The outcome of MSCI’s decision and how MicroStrategy adapts will likely hold valuable insights for others in this rapidly shifting economic terrain. As the firm prepares for potential changes, the market will closely watch how it balances its Bitcoin strategy with broader corporate objectives.

In conclusion, while MicroStrategy’s current predicament raises questions about the sustainability and risks of large Bitcoin holdings, it also underscores the transformative impact of digital currencies on traditional business models. The firm’s experience will likely serve as a case study for companies navigating the uncharted waters of cryptocurrency investment, informing future strategies and regulatory developments in the sector.

Post Views: 9

BNB (BNB) is showing renewed bullish momentum after bouncing more than 13% from a local bottom near $800. It traded above $910 on Wednesday, while eyeing a potential push back toward $1,000.

Key takeaways:

BNB’s double bottom, falling wedge breakout, and liquidation pressure align to target $1,020–$1,115 in December.

Failure to hold above $900 could invalidate the bullish setup toward $1,000.

BNB/USD daily chart. Source: TradingViewDouble bottom predicts BNB over $1,000BNB’s rebound is supported by a developing double-bottom pattern on the four-hour chart, which has formed near the $800–$820 demand zone.

After printing two similar lows (Bottom 1 and Bottom 2), the price rebounded sharply, suggesting that selling pressure is fading, and dip buyers are stepping in.

BNB/USDT four-hour chart. Source: TradingViewThe structure typically signals a trend reversal if the price breaks above the pattern’s neckline, which is currently near the $900–$920 resistance range.

A confirmed breakout above this region could open a short-term rally toward $1,020 in December, where the 0.382 Fibonacci retracement line converges.

Failure to hold above the neckline would invalidate the setup, raising the odds of BNB dropping toward its 20-4H (green) and 50-4H (blue) exponential moving averages (EMAs) at around $860.

Short liquidation cluster points to $1,020 BNBBNB’s liquidation heatmap on CoinGlass showed roughly $112.28 million in short liquidation leverage near $1,020, suggesting price momentum could accelerate toward that level in December.

Binance BNB/USDT liquidation heatmap (1 month). Source: CoinGlassLiquidation heatmaps show where leveraged traders are likely to be forced out of their positions. In this case, many traders appear to be betting against BNB near current levels.

Those short positions begin to incur losses and can be automatically closed by exchanges if the price continues to rise due to an emerging recovery outlook for risk assets.

When shorts are liquidated, traders are compelled to buy BNB, thereby creating additional upward pressure on the price. This dynamic can act as a temporary catalyst, drawing price toward the $1,020 liquidation cluster.

Falling wedge breakout boosts BNB recovery chancesBNB pushed out of a multi-week falling wedge, a structure that typically resolves bullish after prolonged sell-offs.

BNB/USDT four-hour chart. Source: TradingViewOn the four-hour chart, BNB broke above the wedge’s descending upper trendline in late November but briefly pulled back to retest it as support, a common and constructive breakout confirmation.

The successful rebound from this retest suggests buyers are regaining control.

The wedge’s measured upside target pointed toward the $1,100–$1,115 region in December if the breakout holds. Trader CryptoBull_360 predicted the BNB price to go even higher toward $1,300 or more.

Source: XHowever, a sustained move back below the former resistance-turned-support zone would weaken the bullish setup, risk trapping breakout traders, and delay any sustained recovery above $1,000.

This article does not contain investment advice or recommendations. Every investment and trading move involves risk, and readers should conduct their own research when making a decision. While we strive to provide accurate and timely information, Cointelegraph does not guarantee the accuracy, completeness, or reliability of any information in this article. This article may contain forward-looking statements that are subject to risks and uncertainties. Cointelegraph will not be liable for any loss or damage arising from your reliance on this information.

He described nearly all cryptocurrencies, except Bitcoin, as high-risk and speculative, noting that most tokens lack fundamental support or clear use cases. Gensler contrasted this with Bitcoin, which he sees as closer to a commodity from a regulatory perspective, highlighting why it occupies a unique position in both the market and investors’ portfolios.
His comments underscore the importance of careful research and cautious decision-making when exploring digital assets.

Bitcoin’s Unique Position in Crypto Markets
Gensler emphasised that Bitcoin’s design, limited supply, and broad adoption make it distinct from the thousands of other tokens on the market. Unlike many altcoins, Bitcoin has clear economic fundamentals and a long track record of security and market participation. For example, institutional investors such as Grayscale and MicroStrategy have incorporated Bitcoin into their portfolios as a store of value, demonstrating trust in its long-term viability.

This has helped Bitcoin weather volatility that has shaken smaller, less-established tokens. Recent market data shows Bitcoin maintains dominance of around 45% of total crypto market capitalisation, reflecting its continued role as a benchmark and perceived safe harbour among digital assets.

GENSLER STILL FIGHTING A WAR THAT ALREADY ENDED

Gensler popped back on Bloomberg today running the exact same script — “speculative,” “volatile,” “no fundamentals,” acting like Bitcoin & crypto are still some rogue asset on the fringe.

It feels like one of those stories you… pic.twitter.com/V5SNmasvDg

— CryptosRus (@CryptosR_Us) December 3, 2025

Meanwhile, altcoins often face dramatic price swings based on hype, speculation, or project announcements rather than fundamental economic activity. Investors chasing short-term gains in these markets may face heightened risks, as many projects lack clear revenue models, sustainable adoption, or robust governance. Gensler’s remarks reinforce the view that tokens without established use cases or strong community support should be approached with caution.

More About Bitcoin
Phong Lee highlighted that large U.S. banks are eager to partner with Strategy. The firm is the world’s largest corporate Bitcoin holder. This aligns with Michael Saylor’s previous prediction that 2026 will be defined by major banks embracing Bitcoin. This is a signal of a shift toward wider institutional adoption.

JUST IN: 🇺🇸 Phong Lee says large U.S. banks want to partner with Strategy because they are the biggest corporate Bitcoin holder in the world

Saylor previously said major banks accepting Bitcoin will be the story of 2026

Something big is coming in 2026 pic.twitter.com/2cFLQiqHJ9

— Bitcoin Archive (@BitcoinArchive) December 3, 2025

By collaborating with Strategy, these banks gain exposure to Bitcoin in a trusted and regulated framework. This reinforces the growing role of digital assets in traditional finance and sets the stage for broader mainstream integration.

Disclaimer
The information provided by Altcoin Buzz is not financial advice. It is intended solely for educational, entertainment, and informational purposes. Any opinions or strategies shared are those of the writer/reviewers, and their risk tolerance may differ from yours. We are not liable for any losses you may incur from investments related to the information given. Bitcoin and other cryptocurrencies are high-risk assets; therefore, conduct thorough due diligence. Copyright Altcoin Buzz Pte Ltd.

Cover image via www.freepik.com

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

Stellar (XLM) has seen a significant jump in volume as the coin plots another rebound move on the crypto market. This comes after Stellar shed over 13% in the last 30 days amid bearish sentiment in the community.

Stellar’s price sends mixed signals despite rebound attemptAs per CoinMarketCap data, Stellar’s trading volume climbed by 37% to $227.7 million in the last 24 hours to wipe out investors betting on a bearish turn. The rise in volume matched a price reversal for XLM, which has been on a downward spiral over the last 30 days.

Meanwhile, there has been a major twist with the price, as its initial uptick to a high of $0.2625 suffered a 2% decline over the past hour. 

This was likely sparked by volatility that has dogged the coin in recent times. As of press time, Stellar exchanged hands at $0.2537, which represents a 5.46% increase within this time frame.

It is worth mentioning that despite the 37% volume spike and more than 5% price gain, Stellar remains in a troubled state. Notably, XLM still trades below critical levels and has not been able to reclaim the $0.30 resistance mark. In fact, since Nov. 13, Stellar has not been able to attain $0.28.

You Might Also Like

This continued bearish outlook has negatively impacted the altcoin in the past month. Market participants might expect the current increase in volume to linger and trigger a further climb in price. Failure to sustain the momentum could cause Stellar to slip and threaten the $0.20 support level.

XLM's faltered rallies leave it in defensive positionLess than 10 days ago, the same wave of optimism had spread through the Stellar community when XLM recorded an 8% price gain. 

Some investors thought the price had bottomed out at around $0.2460 as the Relative Strength Index (RSI) stood at 39, signaling oversold sentiment.

However, the coin could not sustain the upward momentum as Zcash (ZEC) continued its rally against Stellar. It will take a sustained price rally for XLM to regain its previous level of market capitalization, and proponents are watching.

As of early December 2025, Bitcoin has surged to approximately $93,000, marking a 7% increase over the last 24 hours and a 6% rise over the past week. This advance comes on the heels of a recent dip below $84,000. Bitcoin’s current position at this price level signifies a critical moment, as it tests a significant resistance zone around $93,000.

Analysts are closely monitoring Bitcoin’s performance at this juncture, particularly due to an inverse head-and-shoulders pattern emerging on the 3-hour chart. Such a chart pattern often indicates the potential for a trend reversal, suggesting that if Bitcoin can maintain a break above this resistance, it might aim for the $105,000 to $107,000 range. Crypto Patel, a market analyst, remarked that this breakout could lead to a bullish push towards these higher targets.

However, the confirmation of this uptrend is not assured. Should Bitcoin fail to hold this position, the price action around the neckline will likely dictate its next move. Michaël van de Poppe, another analyst, noted that losing the $92,000 mark could result in a liquidation of long positions, possibly causing a sharp decline. He pointed out that a fallback to the $88,000–$90,000 range would still align with Bitcoin’s prevailing trend. This range has historically acted as a robust support level, providing a cushion during previous consolidations.

If Bitcoin were to drop below $82,400, the lower boundary of the current pattern, it could signal the failure of this bullish setup. Until then, traders anticipate volatility as Bitcoin hovers near this critical resistance.

Short-term bullish momentum remains intact, with Daan Crypto Trades highlighting that Bitcoin has established a higher high and a higher low. This pattern suggests that, technically, the market structure is bullish over this timeframe. He emphasizes a potential short-term target of $97,000–$98,000, provided the current momentum continues. Furthermore, data from Glassnode indicates the formation of short-liquidation clusters, which might contribute to buying pressure as the cryptocurrency moves upward.

Signs of market capitulation and seller exhaustion are becoming more evident. The recent behavior in Bitcoin’s market suggests the possibility of nearing the bottom of the current cycle. Historically, such conditions often precede significant market turning points. Large-scale buybacks and short squeezes have further bolstered the recent upward momentum.

The crypto market is no stranger to volatility. Past cycles have shown that Bitcoin’s price can swing dramatically, often driven by market sentiment, macroeconomic factors, and regulatory changes. For instance, previous bull runs have been followed by steep corrections, reminding investors of the inherent risks in cryptocurrency investments. Additionally, as Bitcoin approaches new highs, it must sustain its momentum amid potential regulatory scrutiny and broader market conditions.

For context, the cryptocurrency market has grown significantly over the past decade, transforming from a niche investment avenue to a mainstream financial asset class. Bitcoin, as the pioneer cryptocurrency, has led this expansion, drawing interest from institutional investors and retail traders alike. The market capitalization of cryptocurrencies has swelled, reaching several trillion dollars at its peak, reflecting its increasing role in global finance.

Despite the bullish outlook, the cryptocurrency space remains fraught with risks. Regulatory actions in major markets, technological vulnerabilities, and macroeconomic shifts can all impact Bitcoin’s price trajectory. For example, stringent regulatory measures or unfavorable policies in key regions like the United States or China could potentially dampen market enthusiasm and trigger a sell-off.

Moreover, Bitcoin’s scalability issues and energy consumption concerns continue to be debated among industry stakeholders. While solutions such as the Lightning Network are being developed to address scalability, the energy-intensive nature of Bitcoin mining remains a contentious topic, particularly in the context of global efforts to combat climate change.

In summary, Bitcoin’s current position at around $93,000 marks a pivotal moment in its price journey. Analysts anticipate possible moves towards $105,000–$107,000 if the breakout above resistance holds. Yet, the path forward is uncertain, contingent on maintaining upward momentum and navigating potential risks. As the market evolves, participants remain vigilant, balancing optimism with caution in the dynamic world of cryptocurrencies.

Post Views: 7

On December 3, 2025, Grayscale Investments introduced the first-ever Chainlink Exchange-Traded Fund (ETF) on NYSE Arca, marking a significant milestone in the evolving landscape of cryptocurrency investment. The launch follows recent regulatory updates that facilitated the listing of such financial instruments. The debut saw impressive trading volumes, reflecting substantial investor interest and confidence in Chainlink’s potential.

Grayscale’s new ETF offers a way for traditional investors to gain exposure to Chainlink, a leading cryptocurrency known for its decentralized oracle network. This network plays a crucial role in connecting blockchain systems with real-world data. The introduction of the Chainlink ETF is particularly timely, as the demand for blockchain technology continues to surge across various sectors, from finance to logistics.

This development is part of a broader trend in the financial markets, where traditional investment firms are increasingly recognizing the viability of cryptocurrencies as asset classes. Grayscale, a pioneer in digital asset management, has been pivotal in bridging the gap between conventional finance and the burgeoning crypto world. The firm’s latest offering allows investors to incorporate Chainlink into their portfolios without navigating the complexities of directly purchasing and storing cryptocurrencies.

The regulatory landscape has been a critical factor in this ETF’s launch. After a prolonged period of regulatory scrutiny and debate, the U.S. Securities and Exchange Commission (SEC) recently revamped its listing standards, easing the path for crypto-based financial products. This move has been widely welcomed by the industry, as it signals a shift towards greater acceptance and integration of digital assets within the mainstream financial system.

The launch of the Chainlink ETF is expected to influence the cryptocurrency market significantly. By providing an accessible avenue for institutional and retail investors alike, it could spur further adoption of Chainlink and similar digital assets. Chainlink’s blockchain network, widely regarded for its security and efficiency, has already been integrated into numerous decentralized applications, enhancing their functionality and reliability.

Despite the positive reception, there are inherent risks associated with the introduction of any crypto-based financial product. Market volatility remains a significant concern, as cryptocurrencies are often subject to rapid and unpredictable price swings. Moreover, the evolving regulatory environment poses uncertainties that could impact the ETF’s performance and the broader crypto market.

Investors should also consider the competitive landscape, as numerous blockchain projects are vying to establish themselves as industry leaders. While Chainlink has made significant strides as a pioneering oracle solution, new entrants and technological innovations could alter market dynamics.

Historically, the introduction of ETFs has had transformative effects on underlying asset classes, often boosting liquidity and attracting a more diverse investor base. The launch of the Chainlink ETF could similarly enhance the visibility and acceptance of blockchain technologies in traditional investment circles. Grayscale’s initiative might pave the way for other cryptocurrency ETFs, further integrating digital assets into conventional portfolios.

The broader context of this development is notable. As digital currencies gain traction, governments and financial institutions globally are exploring central bank digital currencies (CBDCs) and blockchain applications. The U.S., in particular, has been cautious yet progressive in its approach, seeking to balance innovation with regulation. The approval of crypto ETFs represents a strategic move towards accommodating technological advancements while safeguarding financial stability.

In summary, Grayscale’s Chainlink ETF launch on NYSE Arca marks a pivotal moment in the intersection of cryptocurrency and traditional finance. It highlights the growing institutional acceptance of digital assets and underscores the potential of blockchain technology to revolutionize various industries. While challenges remain, the ETF’s debut is a testament to the resilience and adaptability of the crypto market, offering new opportunities for investors willing to navigate its complexities. As the landscape evolves, continued collaboration between regulators and industry stakeholders will be essential to ensure sustainable growth and innovation in this dynamic field.

Post Views: 7